Cannabis-related laws in the United States are subject to frequent changes. Despite hemp’s removal from the Controlled Substances Act, CBD remains classified as a Schedule I drug by the Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) under federal law.
